Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

CLNN Price Correlated With Financials For Clene

Free historical financial statements for Clene Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 5 quarters since 2021. Compare with CLNN stock chart to see long term trends.

CLNN Stock Compared to Quarterly
External Links ⌄
FinViz Real-Time Quote SeekingAlpha SEC Filings TradingView Yahoo Finance

CLNN Income Statement

Revenue, Net:30000
Revenue Per Share:0.0005
Cost of Goods & Services Sold:null
Selling, General & Admin Expense:4786000
Research & Development Expense:8580000
Total Operating Expenses:13366000
Operating Income:-13354000
Income Taxes:0
Net Income:-13354000
Earnings Per Share, Basic:-0.21
Shares Outstanding, Basic Avg:63256545

CLNN Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:-49000
Net Cash from Operations:-13084000
Net Cash from Operations Per Share:-0.2068
Net Cash from Financing Activities:235000
Property, Plant & Equipment Purchases:936000
Net Cash from Investing Activities:-24522000
Net Change in Cash & Equivalents:-37358000

CLNN Balance Sheet

Cash and Cash Equivalents:12988000
Short-Term Investments:23586000
Accounts Receivable, Net:null
Inventories:38000
Total Current Assets:42449000
Property, Plant & Equipment, Net:5914000
Total Assets:53361000
Accounts Payable:3313000
Total Short-Term Liabilities:5466000
Total Liabilities:51344000

Insider Trading

 
Change
Value
Transaction
SEC Form 4
MATLIN DAVID J   Director
149,610 sh at $3
$374,771
Buy
2022-06-21
MATLIN DAVID J   Director
96,011 sh at $3
$255,389
Buy
2022-06-16
Mosca Alison   Director
5,000 sh at $3
$13,100
Buy
2022-06-16
MATLIN DAVID J   Director
55,000 sh at $3
$168,300
Buy
2022-06-14
MATLIN DAVID J   Director
60,670 sh at $3
$154,822
Buy
2022-06-07
MATLIN DAVID J   Director
35,000 sh at $2
$79,450
Buy
2022-05-27
MATLIN DAVID J   Director
181,818 sh at $2
$400,000
Buy
2022-05-18
Gay Jonathon   Director
10,000 sh at $2
$20,800
Buy
2022-05-17
MATLIN DAVID J   Director
132,891 sh at $3
$400,002
Buy
2022-04-21
MATLIN DAVID J   Director
18,648 sh at $3
$58,933
Buy
2022-03-30

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
1,131,161 sh
-14,525 sh
-1%
$4,457
-$240
Vanguard Group Inc
789,963 sh
-218,872 sh
-22%
$3,112
-$1,024
Kepos Capital Lp
650,000 sh
 
$2,561
Ikarian Capital, LLC
514,283 sh
24,962 sh
5%
$2,026
$20
Geode Capital Management, LLC
384,966 sh
-2,650 sh
-1%
$1,516
-$73
LAIRD NORTON TRUST COMPANY, LLC
268,581 sh
 
$1,058
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
241,737 sh
-8,498 sh
-3%
$952
-$154
Soltis Investment Advisors LLC
218,920 sh
 
$863
Northern Trust Corp
178,326 sh
-8,077 sh
-4%
$703
-$61
Charles Schwab Investment Management Inc
164,309 sh
31,227 sh
23%
$648
$102
Morgan Stanley
97,579 sh
30,300 sh
45%
$385
$109
Alps Advisors Inc
64,040 sh
-7,943 sh
-11%
$252
-$43
Bank Of New York Mellon Corp
61,347 sh
-617 sh
-1%
$242
-$12
Srs Capital Advisors, Inc.
52,250 sh
 
$206
Allspring Global Investments Holdings, LLC
32,129 sh
32,129 sh
NEW
$126
$126
Oppenheimer & Co Inc
25,174 sh
2,960 sh
13%
$99
$8
Veritable, L.P.
20,000 sh
20,000 sh
NEW
$79
$79
Rhumbline Advisers
16,919 sh
1,965 sh
13%
$67
$6
New York State Common Retirement Fund
12,514 sh
 
$49
Deutsche Bank Ag\
10,576 sh
-1,318 sh
-11%
$42
-$7

Data imported from Clene Inc. SEC filings. Check original filings before making any investment decision.

Privacy   Terms© ChartInsight LLC 2022  

All data provided without any warranty because SEC XML files are imported via an automated process. Check original SEC filings before making any investment decision.